Search
for
Sort by
Research 631–660 of 1000+
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Modelling androgen synthesis and action during human sexual differentiation
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Diagnosis of Polycystic Ovary Syndrome using Free Testosterone levels via Surface Enhanced Raman Spectroscopy Induced by Gold Nanostar
- Serum Cystatin C levels in adolescent females: A comparative study between PCOS and Non-PCOS groups
- Pregnancy in a Secondary Infertile Woman with Polycystic Ovarian Syndrome (PCOS) –A Case Report
- Virilización y enfermedad metabólica en mujer postmenopáusica relacionado a hiperplasia e hipertecosis ovárica
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Review of Hair Follicle Dermal Papilla cells as <i>in vitro</i> screening model for hair growth
- PCOS in adolescents
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- ANDROGENETIC ALOPECIA
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- Effect of finasteride in idiopathic hirsutism
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- The Hirsute Woman: Challenges in Evaluation and Management
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency